about
An analysis of the use of hyperoxia for measuring venous cerebral blood volume: comparison of the existing method with a new analysis approachComparison of CO2 in air versus carbogen for the measurement of cerebrovascular reactivity with magnetic resonance imagingMapping the pharmacological modulation of brain oxygen metabolism: The effects of caffeine on absolute CMRO2 measured using dual calibrated fMRI.A forward modelling approach for the estimation of oxygen extraction fraction by calibrated fMRI.Measurement of oxygen extraction fraction (OEF): An optimized BOLD signal model for use with hypercapnic and hyperoxic calibration.MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.MRI measurement of oxygen extraction fraction, mean vessel size and cerebral blood volume using serial hyperoxia and hypercapnia.Extracranial Soft-Tissue Tumors: Repeatability of Apparent Diffusion Coefficient Estimates from Diffusion-weighted MR Imaging.Reduced cerebrovascular reactivity in young adults carrying the APOE ε4 allele.Quantitative measurement of cerebral physiology using respiratory-calibrated MRI.Synaptic distinction of laminar-specific prefrontal-temporal pathways in primates.Assessing the repeatability of absolute CMRO2, OEF and haemodynamic measurements from calibrated fMRI.Calibrated fMRI for mapping absolute CMRO2: Practicalities and prospects.Dual-calibrated fMRI measurement of absolute cerebral metabolic rate of oxygen consumption and effective oxygen diffusivityPhase I Trial of a Selective c-MET Inhibitor ARQ 197 Incorporating Proof of Mechanism Pharmacodynamic StudiesChanges in volumetric and metabolic parameters relate to differences in exposure to sub-concussive head impactsMulti-parametric analysis reveals metabolic and vascular effects driving differences in BOLD-based cerebrovascular reactivity associated with a history of sport concussion
P50
Q33577309-FDBDCC5A-1201-45FE-9F12-D75443AA7916Q37298292-65BC9930-0D90-45E6-ABF4-005141F0F6EDQ38890838-013F5741-C616-4377-B11B-524487ADAF89Q39695844-FEA47AA5-B159-4B98-AC2D-4290910A5399Q40071644-7C8C7B06-F9BE-4981-A345-3F61EEE91F12Q43236780-CF827E87-672B-47B0-9056-8AB467D70982Q46581830-48418968-6BD7-40B0-9EA9-E80026F7190CQ48115847-3FBF62BD-CD41-462F-B583-8DCBF66977A9Q48583004-93D859AE-0B01-40F3-B241-88F5645C9600Q48735665-DE4263D1-84D4-4DAE-B620-8B95F3577EF9Q48777332-E1050794-F626-4A3D-AC67-3AC6A10E453DQ49903778-698EE73C-1972-4353-879A-5D34F45E84E2Q52335531-D77244AF-C6D9-415C-9FAF-54413B36F475Q57065484-715EB613-E3DB-4551-B3D8-6E97177A7881Q62664175-95247E3D-BA95-47DB-86E4-A45113F37521Q91893766-4CDF5F95-D0FF-4778-81CD-3F229E391A33Q92235633-5D7C19F8-90BC-4E7E-A58D-1A4F9C9CD0D0
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michael Germuska
@ast
Michael Germuska
@en
Michael Germuska
@es
Michael Germuska
@nl
Michael Germuska
@sl
type
label
Michael Germuska
@ast
Michael Germuska
@en
Michael Germuska
@es
Michael Germuska
@nl
Michael Germuska
@sl
prefLabel
Michael Germuska
@ast
Michael Germuska
@en
Michael Germuska
@es
Michael Germuska
@nl
Michael Germuska
@sl
P106
P21
P31
P496
0000-0003-0580-4350